Search





Search





Markets
/
Stocks
/
ltrn
/

Lantern Pharma Inc

LTRN

Add to Watchlist

2.630USD

-0.020-0.75%

Close 07-31 16:00（ET）Quotes delayed by 15 min

33.56MMarket Cap

LossP/E TTM

Lantern Pharma Inc

2.630

-0.020-0.75%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

LTRN Cash Flow Statement

You can access the annual and quarterly cash flow statements of Lantern Pharma Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q2

FY2019Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

13.78%-3.77M

29.70%-2.79M

35.27%-3.61M

24.15%-3.94M

-42.60%-4.38M

-17.32%-3.97M

-54.54%-5.58M

-44.51%-5.19M

18.33%-3.07M

-26.85%-3.39M

10.55%-3.61M

-31.45%-3.59M

-12.90%-3.76M

-30.89%-2.67M

13.76%-4.04M

-58.37%-2.73M

-55.18%-3.33M

-30.04%-2.04M

-62.05%-4.68M

-251.52%-1.73M

-205.02%-2.14M

---1.57M

---2.89M

-10.68%-490.87K

-65.19%-703.05K

---443.51K

---425.61K

Net income from continuing operations

26.62%-3.33M

30.65%-4.07M

7.29%-4.18M

12.67%-4.33M

16.62%-4.54M

-40.36%-5.88M

-42.52%-4.51M

-4.49%-4.96M

-40.67%-5.44M

-23.80%-4.19M

-39.60%-3.16M

-5.65%-4.75M

6.16%-3.87M

4.50%-3.38M

44.14%-2.26M

-93.93%-4.49M

-68.08%-4.12M

-22.25%-3.54M

-138.26%-4.05M

-177.95%-2.32M

-413.81%-2.45M

---2.90M

---1.70M

-32.42%-833.42K

-5.13%-477.28K

---629.39K

---453.97K

Operating gains losses

-15.76%3.85K

-10.30%4.10K

-6.54%4.10K

5.71%4.50K

12.63%4.57K

15.07%4.57K

18.27%4.39K

21.28%4.26K

18.81%4.06K

44.02%3.98K

25.92%3.71K

47.21%3.51K

71.85%3.42K

38.62%2.76K

59.56%2.95K

50.95%2.38K

48.10%1.99K

82.16%1.99K

68.98%1.85K

137.24%1.58K

150.56%1.34K

--1.09K

112.10%666.00

70.16%536.00

--314.00

--315.00

Other non-cash items

84.52%-6.33K

-1.87%230.83K

1001.32%1.10M

-90.23%-124.88K

-138.42%-40.86K

273.55%235.22K

-235.29%-121.56K

-351.28%-65.65K

484.33%106.35K

-95.59%-135.53K

-40.33%89.85K

-81.12%26.13K

-72.19%18.20K

-132.95%-69.30K

6011.58%150.57K

262.54%138.36K

--65.44K

--210.34K

---2.55K

---85.12K

----

Change in working capital

-1204.78%-763.35K

-35.96%841.08K

28.17%-656.78K

226.60%381.88K

-96.76%69.09K

49.37%1.31M

-17.19%-914.35K

-144.40%-301.64K

986.56%2.13M

131.17%879.22K

67.15%-780.24K

-39.32%679.39K

-191.16%-240.35K

-61.08%380.34K

-173.92%-2.38M

161.08%1.12M

332.27%263.66K

223.68%977.34K

29.65%-867.23K

81.32%428.85K

124.92%60.99K

--301.95K

---1.23M

31.74%236.52K

-2055.02%-244.77K

--179.53K

--12.52K

-Change in receivables

----

--0.00

----

--0.00

----

--0.00

-Change in prepaid expenses

-137.12%-49.51K

-33.39%415.00K

19.62%201.22K

78.61%-195.51K

-85.20%133.38K

24.76%623.02K

523.89%168.21K

-271.55%-913.95K

865.92%901.02K

-31.22%499.36K

113.63%26.96K

147.49%532.75K

73.27%-117.64K

247.92%726.03K

38.92%-197.76K

-1579.53%-1.12M

-327.01%-440.17K

-173.79%-490.82K

79.79%-323.77K

-208.85%-66.80K

21.53%-103.08K

--665.11K

---1.60M

385.64%61.37K

-191.90%-131.36K

--12.64K

---45.00K

-Change in payables and accrued expense

-4432.76%-705.02K

-36.71%467.00K

21.91%-806.92K

-5.13%627.28K

-101.22%-15.55K

75.72%737.88K

-34.57%-1.03M

269.22%661.18K

1988.12%1.27M

237.39%419.92K

64.08%-767.87K

-92.15%179.07K

-109.06%-67.30K

-120.54%-305.64K

-293.35%-2.14M

344.20%2.28M

352.55%742.52K

574.11%1.49M

-247.18%-543.46K

399.68%513.54K

499.88%164.07K

---313.84K

--369.26K

-38.42%102.77K

-171.33%-41.03K

--166.90K

--57.52K

-Change in other current assets

--10.65K

----

--0.00

---4.72K

-186.56%-6.15K

100.00%0.00

--0.00

--7.10K

---15.08K

-100.00%0.00

--0.00

----

205.18%51.88K

--0.00

-124.72%-17.89K

100.00%0.00

---49.33K

----

--72.38K

---72.38K

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

13.78%-3.77M

29.70%-2.79M

35.27%-3.61M

24.15%-3.94M

-42.60%-4.38M

-17.32%-3.97M

-54.54%-5.58M

-44.51%-5.19M

18.33%-3.07M

-26.85%-3.39M

10.55%-3.61M

-31.45%-3.59M

-12.90%-3.76M

-30.89%-2.67M

13.76%-4.04M

-58.37%-2.73M

-55.18%-3.33M

-30.04%-2.04M

-62.05%-4.68M

-251.52%-1.73M

-205.02%-2.14M

---1.57M

---2.89M

-10.68%-490.87K

-65.19%-703.05K

---443.51K

---425.61K

Investing cash flow

Net cash from continuing investing activities

----

100.00%1.00

-81.67%555.00

-100.00%0.00

-47.72%1.16K

-3995.77%-197.94K

-36.61%3.03K

--4.27K

-75.02%2.22K

-26.94%5.08K

-28.82%4.78K

-100.00%0.00

--8.88K

695400.00%6.96K

92.62%6.71K

18.01%14.18K

----

-99.98%1.00

4.81%3.48K

53.61%12.01K

----

--4.99K

--3.32K

--7.82K

----

Capital expenditures

----

-99.97%1.00

-81.67%555.00

-100.00%0.00

-47.72%1.16K

-39.32%3.08K

-36.61%3.03K

--4.27K

-75.02%2.22K

-26.94%5.08K

-28.82%4.78K

-100.00%0.00

--8.88K

695400.00%6.96K

92.62%6.71K

18.01%14.18K

----

-99.98%1.00

4.81%3.48K

53.61%12.01K

----

--4.99K

--3.32K

--7.82K

----

Net cash flow from disposal of fixed assets

----

100.00%1.00

-81.67%555.00

-100.00%0.00

-47.72%1.16K

-3995.77%-197.94K

-36.61%3.03K

--4.27K

-75.02%2.22K

-26.94%5.08K

-28.82%4.78K

-100.00%0.00

--8.88K

695400.00%6.96K

92.62%6.71K

18.01%14.18K

----

-99.98%1.00

4.81%3.48K

53.61%12.01K

----

--4.99K

--3.32K

--7.82K

----

Net cash flow from investment products

31.15%4.25M

-152.44%-1.70M

767.62%5.93M

1916.60%3.59M

684.98%3.24M

1143.70%3.25M

188.95%683.37K

56.74%-197.80K

41.81%-553.95K

-57.16%261.26K

449.59%236.51K

10.62%-457.24K

-639.32%-952.00K

360.65%609.82K

93.23%-67.65K

97.20%-511.57K

--176.52K

---233.96K

---999.02K

---18.28M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

31.20%4.25M

-149.43%-1.70M

771.40%5.93M

1878.24%3.59M

682.44%3.24M

1245.63%3.45M

193.60%680.35K

55.81%-202.06K

42.12%-556.17K

-57.51%256.18K

411.61%231.73K

13.03%-457.24K

-644.35%-960.88K

357.68%602.86K

92.58%-74.36K

97.13%-525.75K

--176.52K

-4586.66%-233.96K

-30059.72%-1.00M

-233810.23%-18.29M

----

---4.99K

---3.32K

---7.82K

----

Financing cash flow

Cash flow from continuous financing activities

----

--526.46K

12.07%13.44K

----

-100.00%0.00

100.00%0.00

--11.99K

--0.00

--54.72K

---500.00K

--0.00

100.00%0.00

--0.00

100.00%0.00

-103.39%-2.18M

-334309.58%-872.81K

100.00%0.00

-100.00%-1.00

60973.42%64.29M

---261.00

---102.83K

--23.66M

-94.31%105.27K

--0.00

--1.85M

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

-100.00%0.00

--0.00

---102.83K

--158.07K

--53.27K

----

--0.00

Net cash flow from common stock issuance/repurchase

----

--666.21K

--958.34K

----

---500.00K

--0.00

100.00%0.00

--0.00

---2.48M

---939.67K

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--69.00M

--0.00

--26.25M

-100.00%0.00

--0.00

--1.85M

Proceeds from stock option exercised by employees

----

--0.00

--13.44K

----

--0.00

-100.00%0.00

--0.00

100.00%0.00

312.06%299.79K

--66.86K

--0.00

---1.00

39.91%72.75K

--0.00

--52.00K

----

--0.00

Proceeds from issuance of warrants

----

--0.00

--11.99K

--0.00

--54.72K

----

Net cash flow from other financing activities

----

---139.75K

----

--0.00

100.00%0.00

--0.00

100.00%0.00

---4.78M

---261.00

--0.00

---2.75M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

----

--526.46K

12.07%13.44K

----

-100.00%0.00

100.00%0.00

--11.99K

--0.00

--54.72K

---500.00K

--0.00

100.00%0.00

--0.00

100.00%0.00

-103.39%-2.18M

-334309.58%-872.81K

100.00%0.00

-100.00%-1.00

60973.42%64.29M

---261.00

---102.83K

--23.66M

-94.31%105.27K

--0.00

--1.85M

Net cash flow

Beginning cash balance

-41.12%4.42M

3.54%8.39M

-53.29%6.06M

-65.26%6.38M

-65.76%7.51M

-68.31%8.10M

-55.20%12.98M

-44.40%18.36M

-41.88%21.94M

-35.75%25.57M

-34.03%28.96M

-30.03%33.02M

-28.14%37.74M

-28.51%39.80M

-28.44%43.90M

--47.19M

173.15%52.52M

167.61%55.67M

157.81%61.35M

-100.00%0.00

1460.78%19.23M

--20.80M

--23.80M

-66.08%634.25K

176.76%1.23M

--1.87M

--445.16K

Current period cash flow changes

143.67%494.96K

-570.34%-3.97M

147.77%2.33M

94.12%-316.19K

68.34%-1.13M

83.72%-591.74K

-43.66%-4.87M

-32.69%-5.38M

24.21%-3.58M

-76.74%-3.63M

17.35%-3.39M

-23.31%-4.06M

11.41%-4.72M

34.62%-2.06M

27.79%-4.10M

83.57%-3.29M

-108.58%-5.33M

-99.88%-3.14M

-89.77%-5.69M

-186.43%-20.02M

10495.83%62.14M

---1.57M

---3.00M

5322.84%23.16M

-141.97%-597.78K

---443.51K

--1.42M

Effect of exchange rate changes

527.59%17.59K

104.40%2.96K

-101.61%-261.00

146.64%27.93K

128.50%2.80K

-1296.36%-67.21K

232.09%16.17K

276.19%11.32K

-97.27%-9.83K

-148.61%-4.81K

-260.04%-12.24K

78.89%-6.43K

-318.74%-4.98K

825.33%9.90K

--7.65K

---30.43K

--2.28K

--1.07K

----

Ending cash balance

-22.89%4.92M

-41.12%4.42M

3.54%8.39M

-53.29%6.06M

-65.26%6.38M

-65.76%7.51M

-68.31%8.10M

-55.20%12.98M

-44.40%18.36M

-41.88%21.94M

-35.75%25.57M

-34.03%28.96M

-30.03%33.02M

-28.14%37.74M

-28.51%39.80M

319.31%43.90M

-42.00%47.19M

173.15%52.52M

167.61%55.67M

-184.12%-20.02M

12729.97%81.37M

--19.23M

--20.80M

1568.84%23.80M

-66.08%634.25K

--1.43M

--1.87M

Free cash flow

13.80%-3.77M

29.76%-2.79M

35.29%-3.61M

24.21%-3.94M

-42.53%-4.38M

-17.24%-3.97M

-54.42%-5.59M

-44.63%-5.19M

18.46%-3.07M

-26.71%-3.39M

10.58%-3.62M

-30.77%-3.59M

-13.17%-3.77M

-31.23%-2.68M

13.68%-4.04M

-58.09%-2.75M

---3.33M

-29.62%-2.04M

-61.98%-4.69M

-248.41%-1.74M

----

---1.57M

---2.89M

---498.69K

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Lantern Pharma Inc Generate?



Lantern Pharma Inc generated -15.68M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Lantern Pharma Inc's Operating Cash Flow Change Year Over Year?



Lantern Pharma Inc's operating cash flow increased by 11.99% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Lantern Pharma Inc Spend on Capital Expenditures?



Lantern Pharma Inc spent 1.72K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Lantern Pharma Inc's Financing Cash Flow Changed?



Lantern Pharma Inc used 1.50M in financing activities in the latest quarter.

What is free cash flow and why does it matter for LTRN?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Lantern Pharma Inc’s free cash flow in the latest quarter?



Free cash flow was -15.68M reflecting a 12.04% change from the previous year.